M3 USA Presents Landmark Research on Physicians’ Attitudes on Pharmaceutical Sales and Marketing at 2013 ePharma Summit

March 5, 2013

WASHINGTON–(BUSINESS WIRE)–M3 USA (usa.m3.com) presented new data from its CompleteSpecialist series of syndicated market research at the 12th annual ePharma Summit in New York City. The detailed syndicated market research study explores how physician specialists communicate with each of their practice audiences: patients, peers, payers and pharmaceutical companies. The report also details and the respective value and influence specialists ascribe to each type of channel. It is the only study of its kind to date, and it breaks new ground in understanding communication and promotion to the specialties that it covers.

“In leveraging the valued insights from multiple sources within the M3 family we have uncovered some new perspectives. This new data both reinforces and at times challenges conventional wisdom about the communication behavior and habits of physicians”

PatientsMap, a large study developed by SSRI in partnership with M3, demonstrates how physicians treat disease and interact with pharmaceutical companies. PatientsMap extracts its data via a web-survey with over 6,000 US physicians covering more than 380 diseases.

At the conference, Jack Bilson, VP of Product Development & Innovation, shared key findings and analysis in his presentation, What you Know and What is True About Physician Behavior, Communication and Preferences: An Analysis of Pharmaceutical’s Prognosis of Influence in the Medical World.

“In leveraging the valued insights from multiple sources within the M3 family we have uncovered some new perspectives. This new data both reinforces and at times challenges conventional wisdom about the communication behavior and habits of physicians,” says Bilson.

The data that will be presented contains a breakdown of each included specialist’s most respected pharmaceutical sales forces and other valuable information on their digital and real world communication preferences of physicians. As an example the most respected sales forces according to Rheumatologists is as follows:

Most Respected Pharmaceutical Sales Force According to Rheumatologists from PatientsMap
1. Abbott
2. Amgen
3. Pfizer
4. Genetech

About M3

M3 USA is a leader in the online healthcare professional community space. In the US, MDLinx.com is the #1 specialty physician website and #2 overall physician website. M3 is also the founding partner of Networks in Health, an international alliance of online physician communities. In addition to offering online promotional advertising mediums, M3 Global Research has the largest global physician market research panel. This gives M3 an unprecedented and unmatched reach across the planet in both eMarketing to physicians as well all forms of market research for healthcare professionals.

The M3 Group operates in the US, Asia, and Europe with more than 1 million physician members globally via its physician websites such aswww.m3.com, www.mdlinx.com, www.doctors.net.uk, andwww.medigate.net. M3, Inc., a publicly traded company on the Tokyo Stock Exchange (JP: 2413) provides services to healthcare and life science industry to reach out to their audience. M3 services include medical education, ethical drug promotion, market research, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, Oxford, London, and Seoul.

Contacts

M3 USA – MDLinx:
R. Gregory Jones, 908-310-3508
rgjones@mccpr.com
or
SSRI Social Survey Research Information:
Mina Asai, +81 3-3370-3244
miasai@ssri.com